Biofunction Research

36  articles.  
* There may be some overlapped articles listed due to the difference of format.

  1. Yang T, Nakanishi H, Itaka K: Development of a new caged intein for multi-input conditional translation of synthetic mRNA. Scientific reports. 2024.05; 14 (1): 9988. ( PubMed , DOI )

  1. Du X, Yada E, Terai Y, Takahashi T, Nakanishi H, Tanaka H, Akita H, Itaka K: Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery. Pharmaceutics. 2023.09; 15 (9): 2291. ( PubMed , DOI )

  2. Zhang Maorui, Fukushima Yuta, Nozaki Kosuke, Nakanishi Hideyuki, Deng Jia, Wakabayashi Noriyuki, Itaka Keiji: メッセンジャーRNAを用いた血管新生因子と骨形成因子の同時投与による骨再生の増強(Enhancement of bone regeneration by coadministration of angiogenic and osteogenic factors using messenger RNA) Inflammation and Regeneration. 2023.06; 43 1 of 16-16 of 16. ( ichushi )

  1. Jia Deng, Yuta Fukushima, Kosuke Nozaki, Hideyuki Nakanishi, Erica Yada, Yuki Terai, Kenji Fueki, Keiji Itaka: Anti-Inflammatory Therapy for Temporomandibular Joint Osteoarthritis Using mRNA Medicine Encoding Interleukin-1 Receptor Antagonist. Pharmaceutics. 2022.08; 14 (9): ( PubMed , DOI )

  2. Hideyuki Nakanishi, Tatsuyuki Yoshii, Shinya Tsukiji, Hirohide Saito: A protocol to construct RNA-protein devices for photochemical translational regulation of synthetic mRNAs in mammalian cells. STAR Protoc. 2022.06; 3 (2): 101451. ( PubMed , DOI )

  1. Hideyuki Nakanishi: Protein-Based Systems for Translational Regulation of Synthetic mRNAs in Mammalian Cells. Life (Basel). 2021.11; 11 (11): 1192. ( PubMed , DOI )

  2. Hashimoto Yasumasa, Kuniishi Hiroshi, Sakai Kazuhisa, Fukushima Yuta, Du Xuan, Yamashiro Kunihiko, Hori Kei, Motohashi Norio, Imamura Michihiro, Hoshino Mikio, Yamada Mitsuhiko, Araki Toshiyuki, Sakagami Hiroyuki, Takeda Shin'ichi, Itaka Keiji, Ichinohe Noritaka, Muntoni Francesco, Sekiguchi Masayuki, Aoki Yoshitsugu: Brain Dp140 alters glutamatergic transmission and social behaviour in Duchenne muscular dystrophy mouse model NEUROMUSCULAR DISORDERS. 2021.10; 31

  3. Nakanishi H, Yoshii T, Kawasaki S, Hayashi K, Tsutsui K, Oki C, Tsukiji S, Saito H: Light-controllable RNA-protein devices for translational regulation of synthetic mRNAs in mammalian cells. Cell chemical biology. 2021.05; 28 (5): 662-674.e5. ( PubMed , DOI )

  4. Fukushima Yuta, Uchida Satoshi, Imai Hideaki, Nakatomi Hirofumi, Kataoka Kazunori, Saito Nobuhito, Itaka Keiji: Treatment of ischemic neuronal death by introducing brain-derived neurotrophic factor mRNA using polyplex nanomicelle BIOMATERIALS. 2021.03; 270 120681. ( PubMed , DOI )

  5. Nakanishi H, Saito H: Purification of Specific Cell Populations Differentiated from Stem Cells Using MicroRNA-Responsive Synthetic Messenger RNAs. Methods in molecular biology (Clifton, N.J.). 2021; 2312 73-86. ( PubMed , DOI )

  1. Li Jinyu, Sasaki Naoko, Itaka Keiji, Terpstra Margo, Levato Riccardo, Matsusaki Michiya: Regulation of Chondrocyte Differentiation by Changing Intercellular Distances Using Type II Collagen Microfibers ACS BIOMATERIALS SCIENCE & ENGINEERING. 2020.10; 6 (10): 5711-5719. ( PubMed , DOI )

  2. Uchida S, Yanagihara K, Matsui A, Kataoka K, Itaka K: mRNA as a Tool for Gene Transfection in 3D Cell Culture for Future Regenerative Therapy. Micromachines. 2020.04; 11 (4): ( PubMed , DOI )

  3. Nakanishi H, Saito H: Caliciviral protein-based artificial translational activator for mammalian gene circuits with RNA-only delivery. Nature communications. 2020.03; 11 (1): 1297. ( PubMed , DOI )

  1. Hayashi K, Nozaki K, Tan Z, Fujita K, Nemoto R, Yamashita K, Miura H, Itaka K, Ohara S: Enhanced Antibacterial Property of Facet-Engineered TiO2 Nanosheet in Presence and Absence of Ultraviolet Irradiation. Materials (Basel, Switzerland). 2019.12; 13 (1): ( PubMed , DOI )

  2. Nakanishi H, Saito H: Mammalian gene circuits with biomolecule-responsive RNA devices. Current opinion in chemical biology. 2019.10; 52 16-22. ( PubMed , DOI )

  3. Matsumoto Masahito, Itaka Keiji: Pax6の骨およびグルコース代謝の調節における細胞分化を介した二重機能の役割 組織培養研究. 2019.06; 38 (2): 59. ( ichushi )

  4. Lin CY, Crowley ST, Uchida S, Komaki Y, Kataoka K, Itaka K: Treatment of Intervertebral Disk Disease by the Administration of mRNA Encoding a Cartilage-Anabolic Transcription Factor. Molecular therapy. Nucleic acids. 2019.02; 16 162-171. ( PubMed , DOI )

  1. Akitsugu Matsui, Satoshi Uchida, Akimasa Hayashi, Kazunori Kataoka, Keiji Itaka: Prolonged engraftment of transplanted hepatocytes in the liver by transient pro-survival factor supplementation using ex vivo mRNA transfection. J Control Release. 2018.09; 285 1-11. ( PubMed , DOI )

  2. Kayoko Yanagihara, Satoshi Uchida, Shinsuke Ohba, Kazunori Kataoka, Keiji Itaka: Treatment of Bone Defects by Transplantation of Genetically Modified Mesenchymal Stem Cell Spheroids. Mol Ther Methods Clin Dev. 2018.06; 9 358-366. ( PubMed , DOI )

  3. Samuel T Crowley, Kazunori Kataoka, Keiji Itaka: Combined CatWalk Index: an improved method to measure mouse motor function using the automated gait analysis system. BMC Res Notes. 2018.04; 11 (1): 263. ( PubMed , DOI )

  1. Y Anraku, H Kuwahara, Y Fukusato, A Mizoguchi, T Ishii, K Nitta, Y Matsumoto, K Toh, K Miyata, S Uchida, K Nishina, K Osada, K Itaka, N Nishiyama, H Mizusawa, T Yamasoba, T Yokota, K Kataoka: Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain. Nat Commun. 2017.10; 8 (1): 1001. ( PubMed , DOI )

  2. Satoshi Uchida, Naoto Yoshinaga, Kayoko Yanagihara, Eiji Yuba, Kazunori Kataoka, Keiji Itaka: Designing immunostimulatory double stranded messenger RNA with maintained translational activity through hybridization with poly A sequences for effective vaccination. Biomaterials. 2017.09; ( PubMed , DOI )

  3. Nakanishi H, Miki K, Komatsu KR, Umeda M, Mochizuki M, Inagaki A, Yoshida Y, Saito H: Monitoring and visualizing microRNA dynamics during live cell differentiation using microRNA-responsive non-viral reporter vectors. Biomaterials. 2017.06; 128 121-135. ( PubMed , DOI )

  4. Federico Perche, Satoshi Uchida, Hiroki Akiba, Chin-Yu Lin, Masaru Ikegami, Anjaneyulu Dirisala, Toshihiro Nakashima, Keiji Itaka, Kohei Tsumoto, Kazunori Kataoka: Improved Brain Expression of Anti-Amyloid β scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer. Curr Alzheimer Res. 2017.03; 14 (3): 295-302. ( PubMed , DOI )

  1. Nakanishi H, Higuchi Y, Yamashita F, Hashida M: Targeted gene integration using the combination of a sequence-specific DNA-binding protein and phiC31 integrase. Journal of biotechnology. 2014.09; 186 139-47. ( PubMed , DOI )

  1. Nakanishi H, Higuchi Y, Kawakami S, Yamashita F, Hashida M: Comparison of piggyBac transposition efficiency between linear and circular donor vectors in mammalian cells. Journal of biotechnology. 2011.07; 154 (4): 205-8. ( PubMed , DOI )

  1. Nakanishi H, Higuchi Y, Kawakami S, Yamashita F, Hashida M: piggyBac transposon-mediated long-term gene expression in mice. Molecular therapy : the journal of the American Society of Gene Therapy. 2010.04; 18 (4): 707-14. ( PubMed , DOI )

  1. Hideyuki Nakanishi, Keiji Itaka: - 2023.11; 93 (12): 1065-1069.

  2. Hideyuki Nakanishi: Design of mRNA drugs for cell or organ-selective translation Gekkan Saibou. 2023.10; 55 (11): 876-880.

  3. Hideyuki Nakanishi, Keiji Itaka: mRNA drugs and mRNA vaccines The progress of medicine. 2023.04; 285 (5): 340-347.

  4. Hideyuki Nakanishi, Keiji Itaka: mRNA drugs and mRNA vaccines 2023.04; 285 (5): 340-347.

  5. Hideyuki Nakanishi: - 2023.02; 115-136.

  1. Hideyuki Nakanishi, Keiji Itaka: Translational regulation systems for "smart mRNA drugs" that enable controllable or targeted therapeutic effects Drug Delivery System. 2022.07; 37 (3): 209-220.

  2. Hideyuki Nakanishi, Keiji Itaka: Translational regulation systems for "smart mRNA drugs" that enable controlled or targeted therapeutic effects Drug Delivery System. 2022.07; 37 (3): 209-220.

  3. Hideyuki Nakanishi, Keiji Itaka: What we can do with mRNA vaccines and mRNA drugs Farumashia. 2022.05; 58 (5): 415-419. ( DOI )

  1. Hideyuki Nakanishi, Keiji Itaka: Fundamental technologies and applications of messenger RNA (mRNA) therapeutics 2021.10; 39 (17):

To the head of this page.▲